27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Bionano Genomics, Inc. (NASDAQ:BNGO) shares are trading higher after the company announced on Thursday that Novogene has adopted the Saphyr system for genome imaging and incorporated it into their expansive repertoire of genome analysis technology services.
“We believe the addition of Bionano technology could enable Novogene's global customers to achieve comprehensive analysis of platinum genome assembly, and genome structure, including highly accurate detection of genomic structural variations that remain unresolved by current next-generation sequencing (NGS) technology and other methods," the company said in a statement.
Bionano Genomics shares were trading up 45.72% at $1.31 in Thursday’s pre-market session. The stock has a 52-week high of $8 and a 52-week low of 50 cents.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!